| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 08/26/2004 | WO2004071480A1 Use of an extract from mycorrhiza fungi |
| 08/26/2004 | WO2004071479A1 Film foaming hydroalcoholic foam |
| 08/26/2004 | WO2004071477A1 Method of obtaining and treating compounds from ozonized unsaturated vegetable oils for pharmaceutical compositions for medical and veterinary use |
| 08/26/2004 | WO2004071400A2 Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity |
| 08/26/2004 | WO2004071391A2 Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders |
| 08/26/2004 | WO2004071208A1 Skin composition |
| 08/26/2004 | WO2004056991A3 Novel angiogenic molecular target and uses thereof |
| 08/26/2004 | WO2004002411A3 Hair and nail treatments using alkanolamines |
| 08/26/2004 | WO2003103585A3 Methods of treating angiogenesis, tumor growth, and metastasis |
| 08/26/2004 | WO2003087296A3 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells |
| 08/26/2004 | WO2003070911A3 Rna interference mediated inhibition of type 1 insulin-like growth factor receptor (igf-1r) |
| 08/26/2004 | WO2003055440A3 Compositions and methods for the treatement of immune related diseases |
| 08/26/2004 | WO2002102320A3 Fce fusion proteins for treatment of allergy and asthma |
| 08/26/2004 | WO2001051003A3 Use of lipid conjugates in the treatment of disease |
| 08/26/2004 | US20040167341 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 08/26/2004 | US20040167332 Boronic ester and acid compounds, synthesis and uses |
| 08/26/2004 | US20040167223 Topical antibacterial formulations |
| 08/26/2004 | US20040167176 Tricyclic compounds useful as angiotensin II agonists |
| 08/26/2004 | US20040167174 Substituted acylhydroxamic acids and method of reducing TNFalpha levels |
| 08/26/2004 | US20040167160 Skin disorders; controlling cell differentiation; antidiabetic agents; cardiovascular disorders; anticancer agents; central nervous system disorders |
| 08/26/2004 | US20040167141 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 08/26/2004 | US20040167104 26,27-Homologated-20-epi-2-alkylidene-19-nor-vitamin D compounds |
| 08/26/2004 | US20040167089 Immunostimulatory nucleic acid molecules |
| 08/26/2004 | US20040167077 Prevent skin damage; therapy for skin disorders |
| 08/26/2004 | US20040166171 Antiulcer agents; anaerobic infections |
| 08/26/2004 | US20040166127 Skin preparation |
| 08/26/2004 | DE4420690B4 Verwendung von Chaulmoograölen auf dem Gebiet der Kosmetik und Pharmazie, insbesondere der Dermatologie zum Abgleich der Pigmentierung der Haut Use of Chaulmoograölen in the field of cosmetics and pharmaceuticals, especially dermatology to balance skin pigmentation |
| 08/26/2004 | DE10305811A1 Surgical implant, preferably in net form, comprises basic structure containing anabolic steroid and corticosteroid to accelerate healing and reduce scar contraction |
| 08/26/2004 | DE10305089A1 Neue heteroarylsubstituierte Acetonderivate als Hemmstoffe der Phospholiphase A2 New heteroaryl substituted acetone derivatives as inhibitors of phospholipase A2 |
| 08/26/2004 | CA2515676A1 Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders |
| 08/26/2004 | CA2514244A1 Benzyl urea and thiourea derivatives useful as androgen antagonists |
| 08/26/2004 | CA2512766A1 Compounds which are modulators of the ppar-type receptors and their use in cosmetic or pharmaceutical compositions |
| 08/25/2004 | EP1449847A1 Glycyrrhetinic acid esters for the treatment of acne |
| 08/25/2004 | EP1449843A1 Intermediates for the preparation of carbamoyl tetrahydropyridine derivatives |
| 08/25/2004 | EP1449537A2 Methods for treating hypercoagulable states or acquired protein C deficiency |
| 08/25/2004 | EP1449536A1 Prion proteins (PrP) as therapeutic agents for the treatment of AP-1 associated diseases |
| 08/25/2004 | EP1449534A1 Matrix metalloprotease inhibitor |
| 08/25/2004 | EP1449529A1 Protein Kinase C Inhibitors |
| 08/25/2004 | EP1449511A1 Use of Idebenone for the preservation of compositions |
| 08/25/2004 | EP1448995A1 Assay for screening candidate drugs for the treatment of inflammatory diseases |
| 08/25/2004 | EP1448591A1 17alpha-alkyl-17beta-oxy-estratrienes and intermediates for the production thereof, and use of said 17alpha-alkyl-17beta-oxy-estratrienes for producing medicaments and pharmaceutical preparations |
| 08/25/2004 | EP1448564A2 Substituted indolizine-like compounds and methods of use |
| 08/25/2004 | EP1448556A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors) |
| 08/25/2004 | EP1448552A1 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23 |
| 08/25/2004 | EP1448550A1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity |
| 08/25/2004 | EP1448548A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 08/25/2004 | EP1448545A1 Nf-kb inhibitors |
| 08/25/2004 | EP1448542A1 6-hydroxy isoflavones, derivatives and medicaments involving same |
| 08/25/2004 | EP1448535A1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 08/25/2004 | EP1448529A1 Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies |
| 08/25/2004 | EP1448525A1 Novel piperidine derivatives as modulators of chemokine receptors |
| 08/25/2004 | EP1448524A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 08/25/2004 | EP1448523A1 Heterocyclic compounds and methods of use |
| 08/25/2004 | EP1448521A1 Derivatives of andrimide and moiramide b having antibacterial properties |
| 08/25/2004 | EP1448513A1 Biphenyl-derivatives as p38-kinase inhibitors |
| 08/25/2004 | EP1448508A1 Double esters |
| 08/25/2004 | EP1448234A1 Formulations comprising a cephalosporin compound and their use in treating bacterial infections in cats and dogs |
| 08/25/2004 | EP1448232A1 Anti-proliferative composition |
| 08/25/2004 | EP1448231A1 Topical delivery of codrugs |
| 08/25/2004 | EP1448216A2 Methods for epitope-specific and cytokine/anticytokine combination immunotherapies for modulation of pathogenic immune responses in immune mediated diseases |
| 08/25/2004 | EP1448212A1 Mint extract pharmaceutical compositions |
| 08/25/2004 | EP1448208A2 Composition based on diosgenin ester for topical use |
| 08/25/2004 | EP1448205A2 Combinations for the treatment of immunoinflammatory disorders |
| 08/25/2004 | EP1448199A1 Benzimidazoles useful as protein kinase inhibitors |
| 08/25/2004 | EP1448195A1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation |
| 08/25/2004 | EP1448192A2 Novel methods of treating local fungal and bacterial infections |
| 08/25/2004 | EP1448186A1 Medicament for the treatment of viral skin and tumour diseases |
| 08/25/2004 | EP1448176A2 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion |
| 08/25/2004 | EP1448155A1 Use of at least one abl, kit and/or platelet-derived growth factor receptor tyrosine kinases inhibitor for treating hair depigmentation |
| 08/25/2004 | EP1448150A2 Treatment of hyperproliferative diseases using active vitamin d analogues |
| 08/25/2004 | EP1343764B1 Urea and urethane derivatives as integrin inhibitors |
| 08/25/2004 | EP1212067A4 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 08/25/2004 | EP1169337B1 Steroid nitrates for the treatment of oxidative injury and endothelial dysfunction |
| 08/25/2004 | EP1086080B1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 08/25/2004 | EP1083903B1 Bridged indenopyrrolocarbazoles |
| 08/25/2004 | EP1064018B1 The use of isolated domains of type iv collagen to modify cell and tissue interactions |
| 08/25/2004 | CN1524081A Pyrimidine derivatives for inhibition of cell proliferation |
| 08/25/2004 | CN1524080A Phthalatyinone-piperidino-derivatives as pde4 inhibitors |
| 08/25/2004 | CN1524003A Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 08/25/2004 | CN1523992A Compositions and methods for treating amyloidosis |
| 08/25/2004 | CN1523981A A pharmaceutical tablet having a high API content |
| 08/25/2004 | CN1522758A Topical compound interferon preparation |
| 08/25/2004 | CN1522750A Acne removing pill process and formulation |
| 08/25/2004 | CN1522741A Tinea liquid medicine and its preparation method |
| 08/25/2004 | CN1522736A Oral medication for treating psoriasis |
| 08/25/2004 | CN1522729A Acne eliminating cathartic pill preparation method |
| 08/25/2004 | CN1522717A Trauma treating medicament and method for making same |
| 08/25/2004 | CN1522689A Leech extract cosmetics and method for making same |
| 08/25/2004 | CN1163511C Yolk anti-interleukin -8 antibody, preparation method and its application |
| 08/25/2004 | CN1163484C 4-Aroyl-Piperidin-CCR-3 receptor antagonist III |
| 08/25/2004 | CN1163477C Substituted beta-alanine |
| 08/25/2004 | CN1163475C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivative and use as MEK inhibitor thereof |
| 08/25/2004 | CN1163269C Medicinal composition containing aloe and its preparing process and application |
| 08/25/2004 | CN1163261C Method of treating skin pigmentation |
| 08/25/2004 | CN1163257C Skin injury regenerating medicine and its preparing process |
| 08/25/2004 | CN1163254C Medicine for treating burn |
| 08/25/2004 | CN1163247C Traditional Chinese medicine liniment for external application for curing psoriasis |
| 08/25/2004 | CN1163245C Disease dispelling agent |
| 08/25/2004 | CN1163241C psoriasis medicine and preparation method |
| 08/25/2004 | CN1163218C Skin-protecting cosmetics |